Episode 17 HOW X-ZELL MADE 2020 work – and why the best is yet to come For many of us, 2020 has been more disruptive, heartbreaking and disorienting than we could have imagined – both personally and professionally. Marred with loss and uncertainty, political...
Episode 16 Thriving in Adversity: how health tech start-ups are navigating Covid-19 It didn’t take long for the first wave of defeatism to hit the start-up community. On 1 April 2020, less than a month after Italy became the first country to impose a national lockdown...
Episode 15 A start-up’s guide to braving the Corona crisis The COVID-19 pandemic is not only placing unprecedented stress on the global healthcare system, but also challenging some of the most fundamental paradigms of modern business culture. Entire nations are going...
Episode 14 Inside Europe’s push for early cancer detection Overshadowed by the world’s ongoing battle with the Wuhan coronavirus, the European Commission (EC) announced last week that it is getting serious about early cancer detection. On the back of a bold commitment...
Episode 13 Navigating medical start-up vocabulary “X-ZELL fuses next-generation rare cell detection technology with Artificial Intelligence to catapult pathology into the digital age. The result is an accurate, affordable and scientifically proven method of screening...
Episode 12 Why building on tradition is key to a future without cancer Two years ago, almost to the day, X-ZELL hit a milestone that many say separates the wheat from the chaff – the equally daunting and exhilarating leap from research to commercialisation. Under the...
